What is Exact Sciences Price-to-Operating-Cash-Flow?
As of today (2024-05-01), Exact Sciences's share price is $60.01.
Exact Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.86. Hence, Exact Sciences's Price-to-Operating-Cash-Flow Ratio for today is 69.86.
The historical rank and industry rank for Exact Sciences's Price-to-Operating-Cash-Flow or its related term are showing as below:
EXAS'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 66.97 Med: 141.5 Max: 396.38
Current: 69.85
During the past 13 years, Exact Sciences's highest Price-to-Operating-Cash-Flow Ratio was 396.38. The lowest was 66.97. And the median was 141.50.
Exact Sciences's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $0.38.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.86.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -1.30% per year.
During the past 13 years, Exact Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 49.20% per year. The lowest was -28.60% per year. And the median was 2.10% per year.
Exact Sciences Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Exact Sciences's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Exact Sciences Price-to-Operating-Cash-Flow Chart
|
Exact Sciences Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
146.72 |
- |
- |
85.33 |
|
Exact Sciences Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
231.85 |
88.83 |
85.33 |
Competitive Comparison of Exact Sciences's Price-to-Operating-Cash-Flow
For the Diagnostics & Research subindustry, Exact Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Exact Sciences's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Exact Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Exact Sciences's Price-to-Operating-Cash-Flow falls into.
Exact Sciences Price-to-Operating-Cash-Flow Calculation
Exact Sciences's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 60.01 | / | 0.859 |
| = | 69.86 |
Exact Sciences's Share Price of today is $60.01.
Exact Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Exact Sciences (Exact Sciences) Business Description
Traded in Other Exchanges
Address
5505 Endeavor Lane, Madison, WI, USA, 53719
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
Executives
| Brian Baranick |
officer: Gen. Mgr., Precision Oncology |
441 CHARMANY DRIVE, MADISON WI 53719 |
| Sarah Condella |
officer: SVP, Human Resources |
441 CHARMANY DRIVE, MADISON WI 53719 |
| Timothy J Scannell |
director |
2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002 |
| Everett Cunningham |
officer: Chief Commercial Officer |
C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094 |
| Jeffrey Thomas Elliott |
officer: Chief Financial Officer |
5505 ENDEAVOR LANE, MADISON WI 53719 |
| James Edward Doyle |
director |
5505 ENDEAVOR LANE, MADISON WI 53719 |
| James Herriott |
officer: General Counsel |
5505 ENDEAVOR LANE, MADISON WI 53719 |
| Katherine S Zanotti |
director |
431 E 9TH STREET, HINSDALE IL 60521 |
| Jacob A Orville |
officer: General Manager, New Ventures |
5505 ENDEAVOR LANE, MADISON WI 53719 |
| Kevin T Conroy |
director, officer: Vice President |
5505 ENDEAVOR LANE, MADISON WI 53719 |
| D Scott Coward |
officer: SVP and General Counsel |
441 CHARMANY DRIVE, MADISON WI 53719 |
| Paul J Clancy |
director |
C/O BIOGEN IDEC INC., 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142 |
| Graham Peter Lidgard |
officer: SVP, Chief Scientific Officer |
5505 ENDEAVOR LANE, MADISON WI 53719 |
| Michael S Wyzga |
director |
RADIUS HEALTH, INC., 201 BROADWAY, 6TH FLOOR, CAMBRIDGE MA 02139 |
| Torsten Hoof |
officer: General Manager, International |
301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063 |
Exact Sciences (Exact Sciences) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EXAS has been successfully added to your